Ditchcarbon
  • Contact
  1. Organizations
  2. Crossject Société Anonyme
Public Profile
Medical Device Manufacturing
FR
updated 21 days ago

Crossject Société Anonyme Sustainability Profile

Company website

Crossject Société Anonyme, headquartered in France, is a pioneering company in the pharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2007, Crossject has made significant strides in creating its unique needle-free injection technology, which enhances patient comfort and compliance. The company focuses on several therapeutic areas, including pain management and emergency medicine, with its flagship product, Zeneo, designed to provide rapid and effective medication delivery. Crossject's commitment to innovation has positioned it as a leader in the market, with notable achievements in securing partnerships and advancing its product pipeline. With operations extending across Europe and beyond, Crossject continues to redefine the standards of drug administration, making healthcare more accessible and efficient.

DitchCarbon Score

How does Crossject Société Anonyme's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Crossject Société Anonyme's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

47%

Let us know if this data was useful to you

Crossject Société Anonyme's reported carbon emissions

Crossject Société Anonyme, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Crossject may not yet have established a formal framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for Crossject to consider developing and communicating its climate commitments to align with global standards and expectations.

How Carbon Intensive is Crossject Société Anonyme's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Crossject Société Anonyme's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Crossject Société Anonyme's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Crossject Société Anonyme is in FR, which has a very low grid carbon intensity relative to other regions.

Crossject Société Anonyme's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Crossject Société Anonyme has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Crossject Société Anonyme's Emissions with Industry Peers

Antares Pharma, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Consort Medical plc

GB
•
Health and social work services (85)
Updated 1 day ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 24 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy